| 1 | Cost-effectiveness of monitoring and liver cancer surveillance among patients with inactive chronic hepatitis B | 2.3 | 6 | Citations (PDF) |
| 2 | Effectiveness and Cost-Effectiveness of Expanded Targeted Testing and Treatment of Latent Tuberculosis Infection Among the Medicare Population in 2022 | 9.6 | 3 | Citations (PDF) |
| 3 | Distribution and transmission of M. tuberculosis in a high-HIV prevalence city in Malawi: A genomic and spatial analysis | 2.1 | 4 | Citations (PDF) |
| 4 | Use of No-Cost Preventive Services Jeopardized by Kennedy v Braidwood | 3.7 | 4 | Citations (PDF) |
| 5 | Balancing Efficiency and Equity in Population-Wide CKD Screening | 6.6 | 7 | Citations (PDF) |
| 6 | Cost-effectiveness of screening with transcriptional signatures for incipient TB among U.S. migrants | 8.0 | 3 | Citations (PDF) |
| 7 | Health and Economic Impact of Periodic Hepatitis C Virus Testing Among People Who Inject Drugs | 3.7 | 4 | Citations (PDF) |
| 8 | The Impact of Rapid Drug Susceptibility Tests on Gonorrhea Burden and the Life Span of Antibiotic Treatments: A Modeling Study Among Men Who Have Sex With Men in the United States | 3.3 | 9 | Citations (PDF) |
| 9 | Bias-Adjusted Predictions of County-Level Vaccination Coverage from the COVID-19 Trends and Impact Survey | 2.2 | 1 | Citations (PDF) |
| 10 | Resource Utilization and Costs Associated with Approaches to Identify Infants with Early-Onset Sepsis | 1.3 | 3 | Citations (PDF) |
| 11 | Disparities in Tuberculosis Incidence by Race and Ethnicity Among the U.S.-Born Population in the United States, 2011 to 2021 | 9.6 | 14 | Citations (PDF) |
| 12 | State-level population estimates of sexual minority adolescents in the United States: A predictive modeling study | 2.3 | 3 | Citations (PDF) |
| 13 | Assessing thresholds of resistance prevalence at which empiric treatment of gonorrhea should change among men who have sex with men in the US: A cost-effectiveness analysis | 8.0 | 2 | Citations (PDF) |
| 14 | Potential impact of curative and preventive interventions toward hepatitis C elimination in people who inject drugs–A network modeling study | 3.3 | 6 | Citations (PDF) |
| 15 | Modelling the potential impact of global hepatitis B vaccination on the burden of chronic hepatitis B in the United States | 1.9 | 2 | Citations (PDF) |
| 16 | Water First School Water Promotion and Access Intervention: A Cost Analysis Study | 1.5 | 1 | Citations (PDF) |
| 17 | When to Start Population-Wide Screening for Chronic Kidney Disease | 3.7 | 9 | Citations (PDF) |
| 18 | Estimation of the Lifetime Quality-Adjusted Life Years (QALYs) Lost Due to Syphilis Acquired in the United States in 2018 | 5.2 | 22 | Citations (PDF) |
| 19 | Population Immunity to Pre-Omicron and Omicron Severe Acute Respiratory Syndrome Coronavirus 2 Variants in US States and Counties Through 1 December 2021 | 5.2 | 20 | Citations (PDF) |
| 20 | Generating simple classification rules to predict local surges in COVID-19 hospitalizations | 1.4 | 7 | Citations (PDF) |
| 21 | The Estimated Lifetime Quality-Adjusted Life-Years Lost Due to Chlamydia, Gonorrhea, and Trichomoniasis in the United States in 2018 | 3.7 | 25 | Citations (PDF) |
| 22 | Costs, Health Benefits, and Cost-Effectiveness of Chlamydia Screening and Partner Notification in the United States, 2000–2019: A Mathematical Modeling Analysis | 1.2 | 13 | Citations (PDF) |
| 23 | Vaccination and Voting Patterns in the U.S.: Analysis of COVID-19 and Flu Surveys From 2010 to 2022 | 3.2 | 7 | Citations (PDF) |
| 24 | Gaps and Disparities in Chronic Hepatitis B Monitoring and Treatment in the United States, 2016-2019 | 1.8 | 20 | Citations (PDF) |
| 25 | Gaps in Prenatal Hepatitis B Screening and Management of HBsAg Positive Pregnant Persons in the U.S., 2015–2020 | 3.2 | 27 | Citations (PDF) |
| 26 | Changes in Population Immunity Against Infection and Severe Disease From Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variants in the United States Between December 2021 and November 2022 | 5.2 | 43 | Citations (PDF) |
| 27 | Use of Wastewater Metrics to Track COVID-19 in the US | 6.6 | 30 | Citations (PDF) |
| 28 | Adaptive metrics for an evolving pandemic: A dynamic approach to area-level COVID-19 risk designations | 7.5 | 4 | Citations (PDF) |
| 29 | Resistance-minimising strategies for introducing a novel antibiotic for gonorrhoea treatment: a mathematical modelling study | 12.3 | 20 | Citations (PDF) |
| 30 | Cost-Effectiveness of 1-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United States | 5.2 | 64 | Citations (PDF) |
| 31 | Trends, Mechanisms, and Racial/Ethnic Differences of Tuberculosis Incidence in the US-Born Population Aged 50 Years or Older in the United States | 5.2 | 16 | Citations (PDF) |
| 32 | The Health and Economic Benefits of Tests That Predict Future Progression to Tuberculosis Disease | 2.8 | 11 | Citations (PDF) |
| 33 | Problems with evidence assessment in COVID-19 health policy impact evaluation: a systematic review of study design and evidence strength | 1.9 | 26 | Citations (PDF) |
| 34 | Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Among Incarcerated People in California State Prisons: Retrospective Cohort Study | 5.2 | 22 | Citations (PDF) |
| 35 | Cost-Effectiveness of Dapagliflozin for Non-diabetic Chronic Kidney Disease | 2.4 | 35 | Citations (PDF) |
| 36 | Evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibiotics | 3.1 | 4 | Citations (PDF) |
| 37 | Model-Estimated Association Between Simulated US Elementary School–Related SARS-CoV-2 Transmission, Mitigation Interventions, and Vaccine Coverage Across Local Incidence Levels | 6.6 | 21 | Citations (PDF) |
| 38 | Affordability and Value in Decision Rules for Cost-Effectiveness: A Survey of Health Economists | 1.9 | 7 | Citations (PDF) |
| 39 | All‐cause versus cause‐specific excess deaths for estimating influenza‐associated mortality in Denmark, Spain, and the United States | 3.4 | 18 | Citations (PDF) |
| 40 | Uptake of COVID-19 Vaccination Among Frontline Workers in California State Prisons | 3.7 | 20 | Citations (PDF) |
| 41 | Cost-Effectiveness of Hepatitis B Testing and Vaccination of Adults Seeking Care for Sexually Transmitted Infections | 1.2 | 11 | Citations (PDF) |
| 42 | Cost-effectiveness of computed tomography versus ultrasound-based surveillance following endovascular aortic repair of intact infrarenal abdominal aortic aneurysms | 1.8 | 8 | Citations (PDF) |
| 43 | Estimated Transmission Outcomes and Costs of SARS-CoV-2 Diagnostic Testing, Screening, and Surveillance Strategies Among a Simulated Population of Primary School Students | 8.5 | 20 | Citations (PDF) |
| 44 | Metamodeling for Policy Simulations with Multivariate Outcomes | 2.2 | 10 | Citations (PDF) |
| 45 | Evaluating the Performance of Centers for Disease Control and Prevention COVID-19 Community Levels as Leading Indicators of COVID-19 Mortality | 9.6 | 7 | Citations (PDF) |
| 46 | Differences in healthy longevity by HIV status and viral load among older South African adults: an observational cohort modelling study | 7.9 | 25 | Citations (PDF) |
| 47 | Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling study | 1.9 | 32 | Citations (PDF) |
| 48 | Protection against Omicron from Vaccination and Previous Infection in a Prison System | 34.5 | 67 | Citations (PDF) |
| 49 | A review of network simulation models of hepatitis C virus and HIV among people who inject drugs | 3.3 | 19 | Citations (PDF) |
| 50 | Adaptive Policies to Balance Health Benefits and Economic Costs of Physical Distancing Interventions during the COVID-19 Pandemic | 2.2 | 10 | Citations (PDF) |
| 51 | The Use and Misuse of Mathematical Modeling for Infectious Disease Policymaking: Lessons for the COVID-19 Pandemic | 2.2 | 124 | Citations (PDF) |
| 52 | Mapping Inequality in SARS-CoV-2 Household Exposure and Transmission Risk in the USA | 2.4 | 3 | Citations (PDF) |
| 53 | Better Late Than Never: Trends in COVID-19 Infection Rates, Risk Perceptions, and Behavioral Responses in the USA | 2.4 | 14 | Citations (PDF) |
| 54 | Patterns of heavy drinking behaviour over age and birth cohorts among Chinese men: a Markov model | 1.9 | 4 | Citations (PDF) |
| 55 | How do Japanese rate the severity of different diseases and injuries?—an assessment of disability weights for 231 health states by 37,318 Japanese respondents | 2.2 | 25 | Citations (PDF) |
| 56 | Developing and evaluating a frailty index for older South Africans—findings from the HAALSI study | 1.8 | 16 | Citations (PDF) |
| 57 | Racial/Ethnic Disparities In COVID-19 Exposure Risk, Testing, And Cases At The Subcounty Level In California | 5.1 | 139 | Citations (PDF) |
| 58 | Concordance between fasting plasma glucose and HbA
1c
in the diagnosis of diabetes in black South African adults: a cross-sectional study | 1.9 | 14 | Citations (PDF) |
| 59 | Impact Evaluation of Coronavirus Disease 2019 Policy: A Guide to Common Design Issues | 3.3 | 46 | Citations (PDF) |
| 60 | Modeling the Cost-Effectiveness of Express Multisite Gonorrhea Screening Among Men Who Have Sex With Men in the United States | 1.2 | 10 | Citations (PDF) |
| 61 | COVID-19 in the California State Prison System: an Observational Study of Decarceration, Ongoing Risks, and Risk Factors | 2.4 | 55 | Citations (PDF) |
| 62 | Cost-effectiveness of Dapagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction | 11.1 | 92 | Citations (PDF) |
| 63 | Passing the Test: A Model-Based Analysis of Safe School-Reopening Strategies | 9.6 | 30 | Citations (PDF) |
| 64 | Multimorbidity and mortality in an older, rural black South African population cohort with high prevalence of HIV findings from the HAALSI Study | 1.9 | 24 | Citations (PDF) |
| 65 | Health Disparities And COVID-19: The Authors Reply | 5.1 | 0 | Citations (PDF) |
| 66 | Outbreaks of COVID-19 variants in US prisons: a mathematical modelling analysis of vaccination and reopening policies | 18.7 | 44 | Citations (PDF) |
| 67 | Nationwide cost-effectiveness analysis of surgical stabilization of rib fractures by flail chest status and age groups | 2.4 | 21 | Citations (PDF) |
| 68 | Time Since Infection and Risks of Future Disease for Individuals with Mycobacterium tuberculosis Infection in the United States | 2.8 | 55 | Citations (PDF) |
| 69 | Dependence of COVID-19 Policies on End-of-Year Holiday Contacts in Mexico City Metropolitan Area: A Modeling Study | 1.3 | 6 | Citations (PDF) |
| 70 | Balancing health and financial protection in health benefit package design | 2.4 | 7 | Citations (PDF) |
| 71 | Effectiveness of the mRNA-1273 Vaccine during a SARS-CoV-2 Delta Outbreak in a Prison | 34.5 | 35 | Citations (PDF) |
| 72 | Quantifying and Benchmarking Disparities in COVID-19 Vaccination Rates by Race and Ethnicity | 6.6 | 52 | Citations (PDF) |
| 73 | Adventures in COVID-19 Policy Modeling: Education Edition | 3.4 | 7 | Citations (PDF) |
| 74 | Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae | 13.3 | 207 | Citations (PDF) |
| 75 | The US COVID-19 Trends and Impact Survey: Continuous real-time measurement of COVID-19 symptoms, risks, protective behaviors, testing, and vaccination | 7.5 | 156 | Citations (PDF) |
| 76 | Cost-effectiveness and Budgetary Impact of Hepatitis C Virus Testing, Treatment, and Linkage to Care in US Prisons | 5.2 | 30 | Citations (PDF) |
| 77 | Comparative Modeling of Tuberculosis Epidemiology and Policy Outcomes in California | 8.9 | 16 | Citations (PDF) |
| 78 | HIV treatment cascade for older adults in rural South Africa | 2.4 | 19 | Citations (PDF) |
| 79 | Potential for Point-of-Care Tests to Reduce Chlamydia-associated Burden in the United States: A Mathematical Modeling Analysis | 5.2 | 30 | Citations (PDF) |
| 80 | The Potential Population-Level Impact of Different Gonorrhea Screening Strategies in Baltimore and San Francisco: An Exploratory Mathematical Modeling Analysis | 1.2 | 10 | Citations (PDF) |
| 81 | The effects of changes in distance to nearest health facility on under-5 mortality and health care utilization in rural Malawi, 1980–1998 | 2.5 | 43 | Citations (PDF) |
| 82 | Population-level Benefits of Extragenital Gonorrhea Screening Among Men Who Have Sex With Men: An Exploratory Modeling Analysis | 1.2 | 24 | Citations (PDF) |
| 83 | Hepatitis C Management at Federally Qualified Health Centers during the Opioid Epidemic: A Cost-Effectiveness Study | 2.0 | 8 | Citations (PDF) |
| 84 | Estimation and correction of bias in network simulations based on respondent-driven sampling data | 3.4 | 4 | Citations (PDF) |
| 85 | High-resolution estimates of tuberculosis incidence among non-U.S.-born persons residing in the United States, 2000–2016 | 2.2 | 15 | Citations (PDF) |
| 86 | Mathematical modeling study of school-based chlamydia screening: potential impact on chlamydia prevalence in intervention schools and surrounding communities | 3.1 | 4 | Citations (PDF) |
| 87 | Policy Implications of Mathematical Modeling of Latent Tuberculosis Infection Testing and Treatment Strategies to Accelerate Tuberculosis Elimination | 2.1 | 3 | Citations (PDF) |
| 88 | Modeling Contact Tracing Strategies for COVID-19 in the Context of Relaxed Physical Distancing Measures | 6.6 | 42 | Citations (PDF) |
| 89 | Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis | 13.3 | 19 | Citations (PDF) |
| 90 | Limitations of the UNAIDS 90-90-90 metrics: a simulation-based comparison of cross-sectional and longitudinal metrics for the HIV care continuumAids, 2020, 34, 1047-1055 | 2.5 | 20 | Citations (PDF) |
| 91 | HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid Epidemic | 2.4 | 21 | Citations (PDF) |
| 92 | Impact of Effective Global Tuberculosis Control on Health and Economic Outcomes in the United States | 8.9 | 23 | Citations (PDF) |
| 93 | Self‐rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE‐ON trials | 2.9 | 11 | Citations (PDF) |
| 94 | Adaptive guidelines for the treatment of gonorrhea to increase the effective life span of antibiotics among men who have sex with men in the United States: A mathematical modeling study | 8.0 | 14 | Citations (PDF) |
| 95 | Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3 | 62.1 | 138 | Citations (PDF) |
| 96 | Evaluation of 6-Month Versus Continuous Isoniazid Preventive Therapy for Mycobacterium tuberculosis in Adults Living With HIV/AIDS in Malawi | 1.8 | 4 | Citations (PDF) |
| 97 | SUN-616 Poor Diagnostic Concordance Between Fasting Plasma Glucose and Glycosylated Hemoglobin in a Black South African Population | 0.3 | 1 | Citations (PDF) |
| 98 | Exploring How Epidemic Context Influences Syphilis Screening Impact: A Mathematical Modeling Study | 1.2 | 10 | Citations (PDF) |
| 99 | Depressive Symptoms and Their Relation to Age and Chronic Diseases Among Middle-Aged and Older Adults in Rural South Africa | 3.4 | 32 | Citations (PDF) |
| 100 | Is knowledge of HIV status associated with sexual behaviours? A fixed effects analysis of a female sex worker cohort in urban Uganda | 3.4 | 18 | Citations (PDF) |
| 101 | The impact of Medicare part D on income-related inequality in pharmaceutical expenditure | 3.2 | 3 | Citations (PDF) |
| 102 | Mapping 123 million neonatal, infant and child deaths between 2000 and 2017 | 37.9 | 233 | Citations (PDF) |
| 103 | Measuring and correcting bias in indirect estimates of under-5 mortality in populations affected by HIV/AIDS: a simulation study | 3.1 | 1 | Citations (PDF) |
| 104 | Multimorbidity and care for hypertension, diabetes and HIV among older adults in rural South Africa | 2.0 | 66 | Citations (PDF) |
| 105 | The Effect of HIV Self-Testing Delivery Models on Female Sex Workers’ Sexual Behaviors: A Randomized Controlled Trial in Urban Uganda | 1.9 | 27 | Citations (PDF) |
| 106 | Modelling hospital operations: insight from using data from paper registries in the obstetrics ward at a hospital in Addis Ababa, Ethiopia | 4.3 | 1 | Citations (PDF) |
| 107 | 302. HCV Care in Federally Qualified Health Centers During the Opioid Epidemic: A Retrospective Cohort Study | 0.8 | 0 | Citations (PDF) |
| 108 | Does Incident Circumcision Lead to Risk Compensation? Evidence From a Population Cohort in KwaZulu-Natal, South Africa | 1.8 | 16 | Citations (PDF) |
| 109 | Integrating Economic Evaluation and Implementation Science to Advance the Global HIV Response | 1.8 | 6 | Citations (PDF) |
| 110 | Short-Term Effects and Long-Term Cost-Effectiveness of Universal Hepatitis C Testing in Prenatal Care | 1.9 | 49 | Citations (PDF) |
| 111 | Spatially targeted screening to reduce tuberculosis transmission in high-incidence settings | 16.5 | 69 | Citations (PDF) |
| 112 | The Impact of Screening and Partner Notification on Chlamydia Prevalence and Numbers of Infections Averted in the United States, 2000–2015: Evaluation of Epidemiologic Trends Using a Pair-Formation Transmission Model | 3.3 | 20 | Citations (PDF) |
| 113 | The State of US Health, 1990-2016 | 16.5 | 1,384 | Citations (PDF) |
| 114 | Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions | 16.5 | 145 | Citations (PDF) |
| 115 | The Burden of Cardiovascular Diseases Among US States, 1990-2016 | 11.1 | 344 | Citations (PDF) |
| 116 | Tuberculosis control interventions targeted to previously treated people in a high-incidence setting: a modelling study | 13.3 | 39 | Citations (PDF) |
| 117 | Population-level Outcomes and Cost-Effectiveness of Expanding the Recommendation for Age-based Hepatitis C Testing in the United States | 5.2 | 63 | Citations (PDF) |
| 118 | Cohort Profile: Health and Ageing in Africa: A Longitudinal Study of an INDEPTH Community in South Africa (HAALSI) | 4.9 | 205 | Citations (PDF) |
| 119 | The Optimal Age for Screening Adolescents and Young Adults Without Identified Risk Factors for HIV | 2.7 | 26 | Citations (PDF) |
| 120 | Feasibility of a Health‐Utility Approach to Quantifying Noneconomic Losses from Personal Injury | 0.8 | 2 | Citations (PDF) |
| 121 | Trading Bankruptcy for Health: A Discrete-Choice Experiment | 1.9 | 19 | Citations (PDF) |
| 122 | Inference With Difference-in-Differences With a Small Number of Groups | 1.8 | 48 | Citations (PDF) |
| 123 | The global burden of tuberculosis: results from the Global Burden of Disease Study 2015 | 16.5 | 311 | Citations (PDF) |
| 124 | Female Sex Workers Often Incorrectly Interpret HIV Self-Test Results in Uganda | 1.8 | 32 | Citations (PDF) |
| 125 | Predictors of male circumcision incidence in a traditionally non-circumcising South African population-based cohort | 2.3 | 10 | Citations (PDF) |
| 126 | Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 62.1 | 4,337 | Citations (PDF) |
| 127 | Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 62.1 | 400 | Citations (PDF) |
| 128 | Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 62.1 | 11,792 | Citations (PDF) |
| 129 | Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017 | 62.1 | 439 | Citations (PDF) |
| 130 | Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 62.1 | 2,798 | Citations (PDF) |
| 131 | Global, regional, and national burden of tuberculosis, 1990–2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study | 16.5 | 238 | Citations (PDF) |
| 132 | The impact of migration on tuberculosis in the United States | 1.3 | 46 | Citations (PDF) |
| 133 | Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016 | 34.5 | 1,382 | Citations (PDF) |
| 134 | Future Directions for Cost-effectiveness Analyses in Health and Medicine | 2.2 | 78 | Citations (PDF) |
| 135 | The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 17.3 | 1,362 | Citations (PDF) |
| 136 | Mortality due to low-quality health systems in the universal health coverage era: a systematic analysis of amenable deaths in 137 countries | 62.1 | 844 | Citations (PDF) |
| 137 | High-quality health systems in the Sustainable Development Goals era: time for a revolution | 13.3 | 3,232 | Citations (PDF) |
| 138 | Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 16.5 | 1,681 | Citations (PDF) |
| 139 | Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016 | 16.5 | 1,277 | Citations (PDF) |
| 140 | The impact of measurement differences on cross-country depression prevalence estimates: A latent transition analysis | 2.3 | 13 | Citations (PDF) |
| 141 | Improving the Validity of Mathematical Models for HIV Elimination by Incorporating Empirical Estimates of Progression Through the HIV Treatment Cascade | 1.8 | 3 | Citations (PDF) |
| 142 | Disability weights for infectious diseases in four European countries: comparison between countries and across respondent characteristics | 0.3 | 15 | Citations (PDF) |
| 143 | Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016 | 62.1 | 863 | Citations (PDF) |
| 144 | Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model | 3.3 | 78 | Citations (PDF) |
| 145 | Estimating the distribution of morbidity and mortality of childhood diarrhea, measles, and pneumonia by wealth group in low- and middle-income countries | 7.1 | 34 | Citations (PDF) |
| 146 | Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 62.1 | 2,900 | Citations (PDF) |
| 147 | Measuring health and economic wellbeing in the Sustainable Development Goals era: development of a poverty-free life expectancy metric and estimates for 90 countries | 13.3 | 24 | Citations (PDF) |
| 148 | Estimated Impact of Screening on Gonorrhea Epidemiology in the United States: Insights From a Mathematical Model | 1.2 | 21 | Citations (PDF) |
| 149 | Treatment gaps and potential cardiovascular risk reduction from expanded statin use in the US and England | 2.3 | 21 | Citations (PDF) |
| 150 | Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys | 21.7 | 133 | Citations (PDF) |
| 151 | The Use of Mathematical Models of Chlamydia Transmission to Address Public Health Policy Questions: A Systematic Review | 1.2 | 24 | Citations (PDF) |
| 152 | Hypertension management in a population of older adults in rural South Africa | 2.1 | 42 | Citations (PDF) |
| 153 | Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 | 14.3 | 4,824 | Citations (PDF) |
| 154 | Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015 | 2.3 | 3,390 | Citations (PDF) |
| 155 | Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015 | 62.1 | 656 | Citations (PDF) |
| 156 | Health Effects of Overweight and Obesity in 195 Countries over 25 Years | 34.5 | 6,881 | Citations (PDF) |
| 157 | Child and Adolescent Health From 1990 to 2015 | 8.5 | 398 | Citations (PDF) |
| 158 | Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015 | 62.1 | 1,616 | Citations (PDF) |
| 159 | Improving Vignette Descriptions and Question Formats to Measure Distance Vision | 1.2 | 5 | Citations (PDF) |
| 160 | Impact of a Text-Messaging Program on Adolescent Reproductive Health: A Cluster–Randomized Trial in Ghana | 2.8 | 84 | Citations (PDF) |
| 161 | Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study | 13.3 | 49 | Citations (PDF) |
| 162 | The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level | 14.3 | 1,855 | Citations (PDF) |
| 163 | Cost-effectiveness of Testing and Treatment for Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Model | 10.6 | 75 | Citations (PDF) |
| 164 | Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 62.1 | 679 | Citations (PDF) |
| 165 | Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 62.1 | 1,857 | Citations (PDF) |
| 166 | Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 62.1 | 4,292 | Citations (PDF) |
| 167 | Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 62.1 | 7,076 | Citations (PDF) |
| 168 | Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 62.1 | 2,198 | Citations (PDF) |
| 169 | Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 | 62.1 | 320 | Citations (PDF) |
| 170 | Sexual Behaviors and HIV Status: A Population-Based Study Among Older Adults in Rural South Africa | 1.8 | 71 | Citations (PDF) |
| 171 | Disparities in Management of Cardiovascular Disease in Rural South Africa | 4.1 | 10 | Citations (PDF) |
| 172 | Impact of Rapid Susceptibility Testing and Antibiotic Selection Strategy on the Emergence and Spread of Antibiotic Resistance in Gonorrhea | 3.7 | 78 | Citations (PDF) |
| 173 | Performance of self‐reported HIV status in determining true HIV status among older adults in rural South Africa: a validation study | 3.4 | 40 | Citations (PDF) |
| 174 | Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1 | 0.8 | 14 | Citations (PDF) |
| 175 | Awareness, treatment, and control of dyslipidemia in rural South Africa: The HAALSI (Health and Aging in Africa: A Longitudinal Study of an INDEPTH Community in South Africa) study | 2.3 | 47 | Citations (PDF) |
| 176 | Prevalence and correlates of frailty in an older rural African population: findings from the HAALSI cohort study | 3.3 | 66 | Citations (PDF) |
| 177 | Hepatitis C Testing Increased Among Baby Boomers Following The 2012 Change To CDC Testing Recommendations | 5.1 | 38 | Citations (PDF) |
| 178 | Diretrizes para o relato preciso e transparente de estimativas de saúde: a Declaração GATHER* | 0.7 | 23 | Citations (PDF) |
| 179 | The Effect of HIV and the Modifying Effect of Anti-Retroviral Therapy (ART) on Body Mass Index (BMI) and Blood Pressure Levels in Rural South Africa | 2.3 | 17 | Citations (PDF) |
| 180 | Sustainable Development in Surgery: The Health, Poverty, and Equity Impacts of Charitable Surgery in Uganda | 2.3 | 28 | Citations (PDF) |
| 181 | Costs of Routine Care for Chronic Hepatitis C Virus Infection: The Case of Illinois Medicaid | 0.8 | 0 | Citations (PDF) |
| 182 | Comparative Effectiveness of Personalized Lifestyle Management Strategies for Cardiovascular Disease Risk Reduction | 4.0 | 50 | Citations (PDF) |
| 183 | Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement | 62.1 | 1,472 | Citations (PDF) |
| 184 | Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 62.1 | 988 | Citations (PDF) |
| 185 | Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models | 13.3 | 172 | Citations (PDF) |
| 186 | Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models | 13.3 | 84 | Citations (PDF) |
| 187 | Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 62.1 | 1,891 | Citations (PDF) |
| 188 | Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 62.1 | 5,762 | Citations (PDF) |
| 189 | Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 62.1 | 6,295 | Citations (PDF) |
| 190 | Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 62.1 | 4,791 | Citations (PDF) |
| 191 | Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 62.1 | 672 | Citations (PDF) |
| 192 | Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015 | 62.1 | 501 | Citations (PDF) |
| 193 | Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses | 16.5 | 2,899 | Citations (PDF) |
| 194 | Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015 | 7.9 | 502 | Citations (PDF) |
| 195 | Diabetes diagnosis and care in sub-Saharan Africa: pooled analysis of individual data from 12 countries | 21.7 | 135 | Citations (PDF) |
| 196 | Costs and cost-effectiveness of a mental health intervention for war-affected young persons: decision analysis based on a randomized controlled trial | 2.6 | 24 | Citations (PDF) |
| 197 | Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement | 8.0 | 296 | Citations (PDF) |
| 198 | A latent transition analysis for the assessment of structured diagnostic interviews. | 1.5 | 3 | Citations (PDF) |
| 199 | HIV burden in men who have sex with men: a prospective cohort study 2007–2012 | 3.4 | 31 | Citations (PDF) |
| 200 | Evaluating the potential impact of enhancing HIV treatment and tuberculosis control programmes on the burden of tuberculosis | 3.2 | 10 | Citations (PDF) |
| 201 | Estimating distributions of health state severity for the global burden of disease study | 2.2 | 82 | Citations (PDF) |
| 202 | Long-term Disability Associated With War-related Experience Among Vietnam Veterans | 1.8 | 16 | Citations (PDF) |
| 203 | Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 | 62.1 | 5,638 | Citations (PDF) |
| 204 | The Global Burden of Cancer 2013 | 14.3 | 2,491 | Citations (PDF) |
| 205 | Using interviewer random effects to remove selection bias from HIV prevalence estimates | 2.5 | 13 | Citations (PDF) |
| 206 | Disability weights for the Global Burden of Disease 2013 study | 13.3 | 1,066 | Citations (PDF) |
| 207 | Assessing disability weights based on the responses of 30,660 people from four European countries | 2.2 | 165 | Citations (PDF) |
| 208 | The Cost-Effectiveness of Sofosbuvir-Based Regimens for Treatment of Hepatitis C Virus Genotype 2 or 3 Infection | 9.6 | 92 | Citations (PDF) |
| 209 | A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys | 21.7 | 262 | Citations (PDF) |
| 210 | Stopping tuberculosis: a biosocial model for sustainable development | 62.1 | 98 | Citations (PDF) |
| 211 | Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition | 62.1 | 1,751 | Citations (PDF) |
| 212 | Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 | 62.1 | 2,474 | Citations (PDF) |
| 213 | Estimating The Potential Impact Of Insurance Expansion On Undiagnosed And Uncontrolled Chronic Conditions | 5.1 | 31 | Citations (PDF) |
| 214 | Improving outcomes for caregivers through treatment of young people affected by war: a randomized controlled trial in Sierra Leone | 2.0 | 12 | Citations (PDF) |
| 215 | Teenage smoking behaviour following a high-school smoking ban in Chile: interrupted time-series analysis | 2.0 | 13 | Citations (PDF) |
| 216 | The Hepatitis C Cascade of Care: Identifying Priorities to Improve Clinical Outcomes | 2.3 | 113 | Citations (PDF) |
| 217 | Assessing and adjusting for differences between HIV prevalence estimates derived from national population-based surveys and antenatal care surveillance, with applications for Spectrum 2013Aids, 2014, 28, S497-S505 | 2.5 | 19 | Citations (PDF) |
| 218 | Who Needs Laboratories and Who Needs Statins? | 4.1 | 25 | Citations (PDF) |
| 219 | The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients | 2.5 | 21 | Citations (PDF) |
| 220 | Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 | 62.1 | 675 | Citations (PDF) |
| 221 | Population Health Impact and Cost-Effectiveness of Monitoring Inactive Chronic Hepatitis B and Treating Eligible Patients in Shanghai, China | 10.1 | 41 | Citations (PDF) |
| 222 | Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 | 62.1 | 840 | Citations (PDF) |
| 223 | Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 | 62.1 | 1,367 | Citations (PDF) |
| 224 | Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models | 13.3 | 202 | Citations (PDF) |
| 225 | The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa | 2.5 | 38 | Citations (PDF) |
| 226 | More Evidence on the Impact of India's Conditional Cash Transfer Program, Janani Suraksha Yojana: Quasi-Experimental Evaluation of the Effects on Childhood Immunization and Other Reproductive and Child Health Outcomes | 2.3 | 78 | Citations (PDF) |
| 227 | The State of US Health, 1990-2010 | 16.5 | 2,318 | Citations (PDF) |
| 228 | UK health performance: findings of the Global Burden of Disease Study 2010 | 62.1 | 508 | Citations (PDF) |
| 229 | Incorporating Loss to Follow-up in Estimates of Survival Among HIV-Infected Individuals in Sub-Saharan Africa Enrolled in Antiretroviral Therapy Programs | 3.7 | 20 | Citations (PDF) |
| 230 | Modelling national HIV/AIDS epidemics: revised approach in the UNAIDS Estimation and Projection Package 2011 | 2.4 | 32 | Citations (PDF) |
| 231 | Spline-based modelling of trends in the force of HIV infection, with application to the UNAIDS Estimation and Projection Package | 2.4 | 22 | Citations (PDF) |
| 232 | HIV Treatment as Prevention: Systematic Comparison of Mathematical Models of the Potential Impact of Antiretroviral Therapy on HIV Incidence in South Africa | 8.0 | 352 | Citations (PDF) |
| 233 | Assessing the population health impact of market interventions to improve access to antiretroviral treatment | 2.6 | 4 | Citations (PDF) |
| 234 | National HIV prevalence estimates for sub-Saharan Africa: controlling selection bias with Heckman-type selection models | 2.4 | 35 | Citations (PDF) |
| 235 | HIV Treatment as Prevention: Issues in Economic Evaluation | 8.0 | 38 | Citations (PDF) |
| 236 | Population Health Impact and Cost-Effectiveness of Tuberculosis Diagnosis with Xpert MTB/RIF: A Dynamic Simulation and Economic Evaluation | 8.0 | 193 | Citations (PDF) |
| 237 | Healthy life expectancy for 187 countries, 1990–2010: a systematic analysis for the Global Burden Disease Study 2010 | 62.1 | 928 | Citations (PDF) |
| 238 | Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 | 62.1 | 1,156 | Citations (PDF) |
| 239 | Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 | 62.1 | 7,673 | Citations (PDF) |
| 240 | Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 | 62.1 | 12,144 | Citations (PDF) |
| 241 | Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 | 62.1 | 7,228 | Citations (PDF) |
| 242 | A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 | 62.1 | 10,151 | Citations (PDF) |
| 243 | Intervention strategies to reduce the burden of non-communicable diseases in Mexico: cost effectiveness analysis | 0.1 | 65 | Citations (PDF) |
| 244 | Effects of Healthcare Reforms on Coverage, Access, and Disparities | 3.2 | 81 | Citations (PDF) |
| 245 | Non-monotonicity in the episodic random utility model | 2.4 | 4 | Citations (PDF) |
| 246 | Flexible epidemiological model for estimates and short-term projections in generalised HIV/AIDS epidemics | 2.4 | 22 | Citations (PDF) |
| 247 | Preferences for health outcomes associated with Group A Streptococcal disease and vaccination | 2.9 | 10 | Citations (PDF) |
| 248 | Event Rates, Hospital Utilization, and Costs Associated with Major Complications of Diabetes: A Multicountry Comparative Analysis | 8.0 | 135 | Citations (PDF) |
| 249 | Clinical Benefits, Costs, and Cost-Effectiveness of Neonatal Intensive Care in Mexico | 8.0 | 45 | Citations (PDF) |
| 250 | Modelling HIV epidemics in the antiretroviral era: the UNAIDS Estimation and Projection package 2009 | 2.4 | 73 | Citations (PDF) |
| 251 | Causes of deaths in children younger than 5 years in China in 2008 | 62.1 | 196 | Citations (PDF) |
| 252 | Quantifying Child Mortality Reductions Related to Measles Vaccination | 2.3 | 23 | Citations (PDF) |
| 253 | New disability weights for the global burden of disease | 2.0 | 52 | Citations (PDF) |
| 254 | THE FIRST AUTHOR REPLIES | 3.3 | 1 | Citations (PDF) |
| 255 | Are Americans Feeling Less Healthy? The Puzzle of Trends in Self-rated Health | 3.3 | 134 | Citations (PDF) |
| 256 | Tracking Population Health Based on Self-reported Impairments: Trends in the Prevalence of Hearing Loss in US Adults, 1976-2006 | 3.3 | 28 | Citations (PDF) |
| 257 | Cost-effectiveness of Rotavirus vaccination in Vietnam | 3.1 | 49 | Citations (PDF) |
| 258 | Keep it simple: Ranking health states yields values similar to cardinal measurement approaches | 3.7 | 47 | Citations (PDF) |
| 259 | Modeling Ranking, Time Trade-Off, and Visual Analog Scale Values for EQ-5D Health States | 1.8 | 66 | Citations (PDF) |
| 260 | Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 Vaccination | 4.6 | 208 | Citations (PDF) |
| 261 | Cost Effectiveness of Alternative Surveillance Strategies for Hepatocellular Carcinoma in Patients With Cirrhosis | 6.0 | 255 | Citations (PDF) |
| 262 | Progress and challenges in modelling country-level HIV/AIDS epidemics: the UNAIDS Estimation and Projection Package 2007 | 2.4 | 58 | Citations (PDF) |
| 263 | Evaluating the impact of antiretroviral therapy on HIV transmissionAids, 2008, 22, S149-S159 | 2.5 | 24 | Citations (PDF) |
| 264 | Impact of HIV on novel therapies for tuberculosis control | 2.5 | 6 | Citations (PDF) |
| 265 | Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves | 2.0 | 51 | Citations (PDF) |
| 266 | Cost-effectiveness of HPV 16, 18 vaccination in Brazil | 3.1 | 143 | Citations (PDF) |
| 267 | Cost-effectiveness of Treatment for Hepatitis C in an Urban Cohort Co-infected with HIV | 2.0 | 22 | Citations (PDF) |
| 268 | Evolution of Antiretroviral Drug Costs in Brazil in the Context of Free and Universal Access to AIDS Treatment | 8.0 | 101 | Citations (PDF) |
| 269 | Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination | 2.2 | 80 | Citations (PDF) |
| 270 | A Risk-Based Method for Modeling Traffic Fatalities | 2.9 | 67 | Citations (PDF) |
| 271 | Priority setting for health interventions in Mexico's System of Social Protection in Health | 62.1 | 103 | Citations (PDF) |
| 272 | Cost-Effectiveness of Treating Multidrug-Resistant Tuberculosis | 8.0 | 97 | Citations (PDF) |
| 273 | The burden of disease and injury in the United States 1996 | 2.2 | 177 | Citations (PDF) |
| 274 | Household and community socioeconomic and environmental determinants of child nutritional status in Cameroon | 3.1 | 143 | Citations (PDF) |
| 275 | Packaging Health Services When Resources Are Limited: The Example of a Cervical Cancer Screening Visit | 8.0 | 29 | Citations (PDF) |
| 276 | Prospects for Advancing Tuberculosis Control Efforts through Novel Therapies | 8.0 | 76 | Citations (PDF) |
| 277 | Health impacts of macroeconomic crises and policies: determinants of variation in childhood malnutrition trends in Cameroon | 4.9 | 61 | Citations (PDF) |
| 278 | Integrating HIV Prevention and Treatment: From Slogans to Impact | 8.0 | 121 | Citations (PDF) |
| 279 | Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries | 0.1 | 170 | Citations (PDF) |
| 280 | Estimating the Net Effect of HIV on Child Mortality in African Populations Affected by Generalized HIV Epidemics | 1.8 | 71 | Citations (PDF) |
| 281 | Illness Transmission in the Home: A Possible Role for Alcohol-Based Hand Gels | 4.5 | 64 | Citations (PDF) |
| 282 | Title is missing! | 2.9 | 62 | Citations (PDF) |
| 283 | Taking account of future technology in cost effectiveness analysis | 0.1 | 23 | Citations (PDF) |
| 284 | Comparability of self rated health: cross sectional multi-country survey using anchoring vignettes | 0.1 | 291 | Citations (PDF) |
| 285 | A multi-method approach to measuring health-state valuations | 2.4 | 64 | Citations (PDF) |
| 286 | Global patterns of healthy life expectancy in the year 2002 | 3.1 | 81 | Citations (PDF) |
| 287 | Reconsidering the use of rankings in the valuation of health states: a model for estimating cardinal values from ordinal data | 2.2 | 93 | Citations (PDF) |
| 288 | Healthy life expectancy: comparison of OECD countries in 2001 | 1.6 | 40 | Citations (PDF) |
| 289 | Modified logit life table system: principles, empirical validation, and application | 2.8 | 128 | Citations (PDF) |
| 290 | Cost-effectiveness of Treatment for Chronic Hepatitis C Infection in an Evolving Patient Population | 16.5 | 217 | Citations (PDF) |
| 291 | Global Patterns of Healthy Life Expectancy for Older Women | 1.5 | 23 | Citations (PDF) |
| 292 | Empirically Calibrated Model of Hepatitis C Virus Infection in the United States | 3.3 | 116 | Citations (PDF) |
| 293 | Can we reverse the HIV/AIDS pandemic with an expanded response? | 62.1 | 143 | Citations (PDF) |
| 294 | The Epidemiologic Transition Revisited: Compositional Models for Causes of Death by Age and Sex | 2.6 | 142 | Citations (PDF) |
| 295 | Healthy life expectancy in 191 countries, 1999 | 62.1 | 339 | Citations (PDF) |
| 296 | Modeling the impact of global tuberculosis control strategies | 7.5 | 222 | Citations (PDF) |
| 297 | Covid-19 Vaccine Acceptance in California State Prisons | 34.5 | 42 | Citations (PDF) |
| 298 | Estimating the undetected burden and the likelihood of strain persistence of drug-resistant Neisseria gonorrhoeae | 3.3 | 1 | Citations (PDF) |
| 299 | Statistical Relationship Between Wastewater Data and Case Notifications for COVID-19 Surveillance in the United States From 2020 to 2023: Bayesian Hierarchical Modeling Approach | 3.8 | 9 | Citations (PDF) |
| 300 | Effects of the COVID-19 Pandemic on Tuberculosis Outcomes in the United States: A Bayesian Analysis | 5.2 | 4 | Citations (PDF) |
| 301 | Cost-Effectiveness of One-time Universal Testing for Hepatitis D Among Adults With Chronic Hepatitis B in the United States | 5.2 | 8 | Citations (PDF) |
| 302 | The Influence of Epidemiologic Context on the Success of Partner Notification Programs: Analysis of Gonorrhea Transmission Dynamics | 3.7 | 1 | Citations (PDF) |
| 303 | Potential Impact of Frequent Testing for Hepatitis C Virus Among People Who Inject Drugs Toward Hepatitis C Elimination in the United States | 5.2 | 4 | Citations (PDF) |
| 304 | National- and State-level SARS-CoV-2 Immunity Trends From January 2020 to December 2023: a Mathematical Modeling Analysis | 3.7 | 2 | Citations (PDF) |
| 305 | Cost-Effectiveness of Nirsevimab and Maternal RSVpreF Immunization Strategies in Low-Risk Infants | 4.5 | 2 | Citations (PDF) |
| 306 | Quantifying the spatiotemporal dynamics of the first two epidemic waves of SARS-CoV-2 infections in the United States | 3.1 | 0 | Citations (PDF) |
| 307 | Clarification of PSA Methods and Corrected CEAC for Universal HDV Testing Among Adults With Chronic HBV | 5.2 | 0 | Citations (PDF) |
| 308 | Preventive service use among Medicaid expansion adults, 2014–2019 0, 4, | | 0 | Citations (PDF) |
| 309 | Indirect state-level estimation of sexual minority adolescent populations by sex, age, and race/ethnicity using random forests | 2.3 | 0 | Citations (PDF) |
